Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society Of Infectious Diseases Pharmacists.
- 1 February 2010
- journal article
- Vol. 31 (1), 21-4
Abstract
The Review is a welcome and up-to-date consensus statement on the use of vancomycin. Although many of the points are pertinent to Australasian practice, the clinical context may be subtly different such that different recommendations apply here. It is thus an apt time for clinical, biochemical, pharmacological and pathology staff in Australasia to collaborate and discuss the literature with particular relevance to establishing guidelines for an Australasian context. The new TG (Version 14) will be an interesting update in the antibiotic TDM area and we hope it will be used as a springboard for Australasian clinical research into this area.This publication has 7 references indexed in Scilit:
- Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrationsJournal of Antimicrobial Chemotherapy, 2009
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases PharmacistsAmerican Journal of Health-System Pharmacy, 2009
- Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of NephrotoxicityAntimicrobial Agents and Chemotherapy, 2008
- Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapyJournal of Antimicrobial Chemotherapy, 2008
- Antimicrobial Dosing Considerations in Obese Adult PatientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides*Critical Care Medicine, 2005
- Continuous versus Intermittent Infusion of Vancomycin in Severe Staphylococcal Infections: Prospective Multicenter Randomized StudyAntimicrobial Agents and Chemotherapy, 2001